- Grants since 2016
- 484
- Awarded, last 5 years (where amounts are published)
- 57M
- Funded works, last 5 years
- 437
- Funded works, all time
- 2 006
Grants
2023 · award
Mapping the genetics of TDP-43 binding in ALS motor neurons
Jack Humphrey · New York Genome Center
2023–2024 · award
Identification of ALS risk factors leading to CHIP-related Epi-age acceleration
Veronique Belzil · Mayo Clinic in Florida
2023–2025 · award
Age-dependent loss of proteasome activity as a driver of TDP-43 mislocalization
Sitao Zhang · The Regents Of The Univ Calif. Uc San Diego
2023–2027 · award
Enhancing ALS Clinical Trials at the Medical College of Wisconsin
Dominic Fee · Medical College of Wisconsin
2023–2024 · award
Motor unit population changes in ALS
Christi Kolarcik · University of Pittsburgh
2023–2025 · award
Partnering to Develop Early Diagnostics for ALS
Melanie Leitner · Massachusetts General Hospital
2023–2025 · award
Clinical trial of a matrix metalloproteinase inhibitor for the treatment of ALS
Irving Sucholeiki · Aquilus Pharmaceuticals (United States)
2023–2026 · award
Diversity and Inclusion in ALS Research throughout Greater New York
Neil Shneider · Columbia University
2023–2025 · award
Understanding and Preventing Virus-triggered ALS
Pascal Falter-Braun · Center for Environmental Health
2023–2024 · award
Structural studies of TDP-43 self-assembly as a therapeutic target for ALS
Jayakrishna Shenoy Krishnashenoy Padmabai · Texas A&M University
2023–2025 · award
Novel therapeutic oligonucleotides for the treatment of sporadic ALS
Annie Collins · University of Massachusetts Chan Medical School
2023–2026 · award
Increasing Kaiser Permanente Southern California ALS Clinical Trial Capacity
Abel Wu · Kaiser Permanente
2023–2024 · award
Biomechanical Investigation of Gait and Myoelectric Activity in ALS Patients
Susan Dandrea · University of Rhode Island
2023–2027 · award
ALS Clinical Trial Readiness in Rural Missourians
Dave Arnold · The Curators Of The University Of Missouri
2023–2024 · award
ASO-mediated stabilization of G3BP1 as a therapy for ALS/FTD
Christine Vande Velde · Centre Hospitalier de l’Université de Montréal
2023 · award
Amyotrophic Lateral Sclerosis prevalence projection in 2040
Adriano Chiò · University of Turin
2023–2025 · award
Modulation of neurodegenerative microglia by nasal anti-CD3 monoclonal antibody
Howard Weiner · Brigham and Women's Hospital
2023–2025 · award
Diabetes and amyotrophic lateral sclerosis
Mario Flores · Harvard University
2023–2026 · award
Mayo Clinic Scottsdale Clinical Trial Capacity Expansion
Stephen Johnson · Mayo Clinic in Arizona
2023–2026 · award
ALS Clinical Trial Expansion to Hispanic Populations in South Florida
Eduardo Locatelli · Nova Southeastern University
2023–2024 · award
Evaluation of metabolic interventions for ALS prevention
Jeehye Park · Hospital for Sick Children
2023–2024 · award
Care Interactions in ALS: An Exploratory Study with non-white Persons
Chelsey Carter · Yale University
2023–2024 · award
Development of a Simoa assay to measure the somatodentritic marker MAP2 in blood
Patrick Oeckl · German Center for Neurodegenerative Diseases
2023–2025 · award
Prodromal mild motor impairment (MMI): characterization in non-genetic ALS
Michael Benatar · University of Miami
2023–2026 · award
Integrating research capacity into the James J. Peters Veterans ALS Clinic
Noam Harel · Bronx Veterans Medical Research Foundation, Inc
2023–2024 · award
Development of an antisense oligonucleotide targeting SYF2 for ALS
Justin Ichida · University of Southern California
2023–2024 · award
Digital assessment tools for ALS & FTD
Penny Dacks · Association for Frontotemporal Degeneration
2023–2025 · award
Development of a novel selective HDAC6 inhibitor for the treatment of ALS
Frederik Rombouts · St. Augustine College
2023–2024 · award
Identification of preclinical ALS biomarker candidates in cerebrospinal fluid by mass spectrometry-based peptidomics
Patrick Oeckl · German Center for Neurodegenerative Diseases
2023–2025 · award
Affordable and Individualized Soft Exosuit for Assisting Upper Limb Manipulation
Hao Su · Picasso Intelligence
2023–2024 · award
In vivo proof-of-concept Target Validation Study in ALS mouse models
Ken Devaney · Target ALS
2023–2024 · award
Developing Novel Therapeutics for ALS-associated Proteotoxicity
Jiou Wang · University of Maryland, Baltimore
2023–2024 · award
Developing bioinformatics infrastructure for ALS genomics analysis in Malaysia
Azlina Ahmad-Annuar · University of Malaya
2023–2027 · award
Development of an ALS Clinical Trials Program at Baylor College of Medicine
Sarah Berth · Baylor College of Medicine
2023–2025 · award
Environmental toxins in ALS: Validation and repurposing therapeutics
Andrew Grierson · University of Sheffield
2023 · award
Study of axonal contents in mice expressing ALS-associated KIF5A mutation
Stephen Kolb · The Ohio State University
2023–2027 · award
Improving and expanding access to clinical trials in the Tri-State region.
Hristelina Ilieva · Thomas Jefferson University
2023–2025 · award
Electromarkers of ALS: Detecting abnormal brain network function before ALS symptoms emerge in C9orf72 mutation-prevalent families
Roisin Mcmackin · The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin
2023–2024 · award
On the Validation Of Tidal/End -tidal CO2 in ALS (VOTECO2ALS)
John Altrip · Papworth Hospital NHS Foundation Trust
2023–2024 · award
Gene therapy for Amyotrophic Lateral Sclerosis
Sapan Gandhi · Drishti Discoveries Ltd